MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.
Kubo T, Yamamoto H, Lockwood WW, Valencia I, Soh J, Peyton M, Jida M, Otani H, Fujii T, Ouchida M, Takigawa N, Kiura K, Shimizu K, Date H, Minna JD, Varella-Garcia M, Lam WL, Gazdar AF, Toyooka S.
Kubo T, et al. Among authors: jida m.
Int J Cancer. 2009 Apr 15;124(8):1778-84. doi: 10.1002/ijc.24150.
Int J Cancer. 2009.
PMID: 19117057
Free PMC article.